Compounds > 15-hydroxy-11-alpha-9-alpha-(epoxymethano)prosta-5-13-dienoic-acid

15-hydroxy-11-alpha-9-alpha-(epoxymethano)prosta-5-13-dienoic-acid and Postoperative-Complications

15-hydroxy-11-alpha-9-alpha-(epoxymethano)prosta-5-13-dienoic-acid has been researched along with Postoperative-Complications* in 1 studies

Other Studies

1 other study(ies) available for 15-hydroxy-11-alpha-9-alpha-(epoxymethano)prosta-5-13-dienoic-acid and Postoperative-Complications

Article	Year
PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications. Thrombosis and haemostasis, 2013, Volume: 110, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Arachidonic Acid; Blood Platelets; Cells, Cultured; Cyclooxygenase 1; Genetic Association Studies; Hemorrhage; Heterozygote; Humans; Male; Platelet Aggregation; Platelet Function Tests; Polymorphism, Single Nucleotide; Postoperative Complications; Recurrence; Thromboxanes; Transcriptome	2013

Article

Year

PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications.

Thrombosis and haemostasis, 2013, Volume: 110, Issue:5

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Arachidonic Acid; Blood Platelets; Cells, Cultured; Cyclooxygenase 1; Genetic Association Studies; Hemorrhage; Heterozygote; Humans; Male; Platelet Aggregation; Platelet Function Tests; Polymorphism, Single Nucleotide; Postoperative Complications; Recurrence; Thromboxanes; Transcriptome

2013